How should I stop taking tepotinib?

Tepotinib is a tyrosine kinase inhibitor used to treat advanced non-small cell lung cancer carrying exon skipping mutations in exon 14 of the MET gene. For patients who are taking tepotinib, discontinuation of the drug needs to be done under the guidance of a doctor to ensure safety and effectiveness. Here are some guidelines on how to stop medication:

Patients will need a detailed medical evaluation before discontinuing the drug. This includes imaging tests (such as CT or MRI) to assess changes in the tumor, blood tests to monitor liver function and other key indicators, and to assess any medication side effects. Your doctor will use these assessments to decide whether the medication needs to be stopped or the dose adjusted.

For some patients, especially those who develop dependence on tepotinib or experience severe side effects, a gradual dose reduction may be necessary rather than stopping suddenly. This helps the body adapt to changes in drug concentrations and reduces the risk of withdrawal reactions. The specific medication reduction plan needs to be formulated based on the individual's condition and the doctor's advice.

During the withdrawal process, patients still need to closely monitor their body's response. If you experience discomfort or worsening of side effects during discontinuation of medication, you should report it to your doctor immediately. Your doctor may prescribe symptomatic treatment, such as providing medications to relieve symptoms or adjusting your medication withdrawal plan if necessary.

While tepotinib is discontinued, your doctor may recommend other treatment options to ensure continued control of your condition. This may include other targeted drugs, chemotherapy or radiation therapy, etc. The choice of new treatment options will be based on the patient's specific condition, the genetic characteristics of the tumor and response to previous treatments.

After stopping the drug, patients will need regular follow-up visits, usually every few months. These follow-up visits include imaging studies and blood tests to monitor changes in the condition and to detect and treat any recurrence or new problems promptly.

During and after discontinuation of medication, patients should maintain a healthy lifestyle, including a balanced diet, moderate exercise, and avoidance of alcohol and smoking. In addition, it is important to maintain mental health, and patients can seek psychological support or attend cancer support groups.

In short, the discontinuation process of tepotinib needs to be carried out under the strict guidance of doctors to ensure safety and effectiveness. Patients should work closely with their physician to follow an individualized treatment and discontinuation plan, undergo regular medical evaluation, and take necessary preventive and management measures to address potential risks.